Market Tracker

09/17 7:19am ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

122.15
Data as of Sep 16
 +0.72 / +0.59%
Today’s Change
100.05
Today|||52-Week Range
153.10
+4.05%
Year-to-Date

Today’s Trading

Previous close121.43
Today’s open121.34
Day’s range-- - --
Volume1,491,611
Average volume (3 months)2,520,943
Market cap$40.5B
Dividend yield--
Data as of 09/16/2014

Growth & Valuation

Earnings growth (last year)-610.53%
Earnings growth (this year)+28.30%
Earnings growth (next 5 years)+57.40%
Revenue growth (last year)+62.68%
P/E ratio--
Price/Sales6.53
Price/Book7.90

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+2.99+1.86%
AGNAllergan Inc+1.64+0.97%
SHPGShire PLC+2.24+0.87%
VRTXVertex Pharmaceutica...+1.73+1.88%
Data as of 09/16/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)$1.97
Annual revenue (last year)$5.8B
Annual profit (last year)-$866.1M
Net profit margin-15.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts